Viatris Inc recalls Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use
Recalled November 16, 2022 · FDA recall D-0058-2023 · Viatris
Hazard
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe. · FDA Class I
Units
22400 syringes
Sold at
Nationwide in the USA
Description
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Product
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).
Manufacturer(s)
Viatris Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →